Translate page

English English
en Englishbg Bulgarianzh-CN Chinese (Simplified)hr Croatiancs Czechda Danishnl Dutchfi Finnishfr Frenchde Germanel Greekiw Hebrewhi Hindiid Indonesianit Italianja Japaneseko Koreanmk Macedonianpl Polishpt Portuguesero Romanianru Russiansr Serbiansk Slovaksl Slovenianes Spanishsv Swedishth Thaitr Turkishvi Vietnamese

Virtual Education

EHA 2019: Special aspects in children (Fréderic Millot)

Millot EHA 2019

Mechanisms for Resistance and TFR in CML: Special Aspects in Children
Professor Fréderic Millot, University of Poitiers, France 

  • Clinical and biological characteristics of childhood CML
  • Mechanisms of failure of tyrosine kinase inhibitors in children with CML
  • Criteria for discontinuation of tyrosine kinase inhibitors in children with CML
  • Childhood CML: Conclusion

 

 

This talk was first presented during the Hematology-in-Focus Session on 'Mechanisms for resistance and treatment-free remission (TFR) in CML' at EHA. You will find more education materials from EHA at the EHA Learning Centre.